Pepsinogen C in Breast Tumours
Author Information
Author(s): I. Diez-Itza, A.M. Merino, J. Tolivia, F. Vizoso, L.M. Sánchez, C. Lopez-Otin
Primary Institution: Universidad de Oviedo
Hypothesis
Can pepsinogen C serve as a marker for good prognosis in breast cancer?
Conclusion
Pepsinogen C expression is significantly associated with better prognostic factors in breast cancer.
Supporting Evidence
- 46% of breast tumors showed positive immunostaining for pepsinogen C.
- Pepsinogen C levels were higher in estrogen receptor positive tumors.
- Well and moderately differentiated tumors had higher pepsinogen C levels than poorly differentiated tumors.
Takeaway
This study found that a protein called pepsinogen C is present in many breast tumors, and its levels can help predict how well a patient might do.
Methodology
Immunohistochemical staining was used to evaluate pepsinogen C expression in breast tumor samples.
Limitations
The study had a short follow-up period for patients.
Participant Demographics
245 women who underwent surgery for primary breast carcinoma, with ages ranging from 26 to 90.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website